Search results
Eli Lilly and Company (LLY) to Issue Quarterly Dividend of $1.30 on June 10th
ETF DAILY NEWS· 4 days agoEli Lilly and Company (NYSE:LLY – Get Free Report) announced a quarterly dividend on Monday, May 6th, RTT News reports. Eli ...
Why Eli Lilly Stock Jumped by 4% Today
Motley Fool via Yahoo Finance· 6 days agoThe largest pharmaceutical company in the world by market cap, Eli Lilly (NYSE: LLY), is continuing to share some of its profits with shareholders. The...
Eli Lilly and Company (NYSE:LLY) Trading 2.6% Higher After Strong Earnings
ETF DAILY NEWS· 6 days agoEli Lilly and Company (NYSE:LLY – Get Free Report) shares rose 2.6% during trading on Monday following a stronger than expected earnings report.
Lilly Declares Second-Quarter 2024 Dividend
WTRF Wheeling· 6 days agoThe board of directors of Eli Lilly and Company (NYSE: LLY) has declared a dividend for the second quarter of 2024 of $1.30 per share on outstanding common ...
What About Eli Lilly's Drug For Early Alzheimer's? FDA Panel To Discuss Next Month
Benzinga via Yahoo Finance· 5 days agoThe open public hearing portion of the meeting will be conducted virtually. The Phase 3 study...
Zacks Investment Ideas feature highlights: Eaton, Eli Lilly and Arista Networks
Zacks· 3 days agoEaton, Eli Lilly and Arista Networks have been highlighted in this Investment Ideas article.
Lilly gets a date with FDA to discuss Alzheimer's med donanemab
FierceBiotech· 5 days agoMark your calendars: Eli Lilly will come before the FDA’s advisory committee to discuss Alzheimer’s...
5 weight-loss drug stocks to watch as Ozempic, Zepbound sales surge
Bankrate via AOL· 4 days agoTreating America’s obesity epidemic is turning into big business. Two pharmaceutical companies, Eli ...
India's Cipla open to partnering with Eli Lilly to market their obesity drugs, CEO says
Reuters· 2 days ago, opens new tab to market its blockbuster obesity treatment drugs in India, the company's CEO said...
US FDA panel to discuss Eli Lilly Alzheimer's drug on June 10
Reuters via Yahoo News· 5 days agoFood and Drug Administration's approval last year. Lilly's donanemab was declined accelerated...